416 related articles for article (PubMed ID: 26711148)
1. Study on the cytotoxic activity of platinum(II) complexes of (1R,2R)-N(1)-cyclopentyl-1,2-cyclohexanediamine with substituted malonate derivatives.
Zhou Z; Chen F; Xu G; Gou S
Bioorg Med Chem Lett; 2016 Jan; 26(2):322-327. PubMed ID: 26711148
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity profile of novel sterically hindered platinum(II) complexes with (1R,2R)-N(1),N(2)-dibutyl-1,2-diaminocyclohexane.
Zhang H; Gou S; Zhao J; Chen F; Xu G; Liu X
Eur J Med Chem; 2015; 96():187-95. PubMed ID: 25874342
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic malonate platinum(II) complexes with 1,2,4-triazolo[1,5-a]pyrimidine derivatives: structural characterization and mechanism of the suppression of tumor cell growth.
Łakomska I; Hoffmann K; Wojtczak A; Sitkowski J; Maj E; Wietrzyk J
J Inorg Biochem; 2014 Dec; 141():188-197. PubMed ID: 25277461
[TBL] [Abstract][Full Text] [Related]
4. Antitumor platinum(II) complexes of N-monoalkyl-1R, 2R-diaminocyclohexane derivatives with alkyl groups as hindrance.
Sun Y; Yin R; Gou S; Zhaojian
J Inorg Biochem; 2012 Jul; 112():68-76. PubMed ID: 22561544
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, antiproliferative activity and DNA binding study of mixed ammine/cyclohexylamine platinum(II) complexes with 1-(substituted benzyl) azetidine-3, 3-dicarboxylates.
Sun Y; Gou S; Yin R; Jiang P
Eur J Med Chem; 2011 Oct; 46(10):5146-53. PubMed ID: 21875765
[TBL] [Abstract][Full Text] [Related]
6. Platinum(II) complexes with N-monoalkyl 1R,2R-diaminocyclohexane derivatives as carrier ligands and 3-hydroxycyclobutane-1,1-dicarboxylate as a leaving group: potent cytotoxicity and DNA binding ability.
Fang L; Gou S; Zhao J; Sun Y; Cheng L
Eur J Med Chem; 2013 Nov; 69():842-7. PubMed ID: 24121235
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and cytotoxicity of diam(m)ineplatinum(II) complexes with 2,2-bis(hydroxymethyl)malonate as the leaving group.
Xing Y; Lou L; Chen X; Ye Q; Xu Y; Xie C; Jiang J; Liu W
Bioorg Med Chem Lett; 2012 Mar; 22(6):2239-41. PubMed ID: 22357340
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, in vitro cytotoxicity, and interaction with DNA of platinum(II) complexes with N-monocycloalkyl derivatives of 1R,2R-diaminocyclohexane as carrier ligands.
Sun Y; Gou S; Liu F; Yin R; Fang L
ChemMedChem; 2012 Apr; 7(4):642-9. PubMed ID: 22247027
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro antiproliferative activity of platinum(II) complexes with N-monoalkyl 1R,2R-diaminocyclohexane as ligands.
Sun Y; Liu F; Gou S; Cheng L; Fang L; Yin R
Eur J Med Chem; 2012 Sep; 55():297-306. PubMed ID: 22867527
[TBL] [Abstract][Full Text] [Related]
10. In vitro biological evaluation of platinum(II) complexes with 1-(methoxy substituted benzyl) azetidine-3,3-dicarboxylato ligands.
Yin R; Gou S; Sun Y; Liu X
Bioorg Med Chem; 2012 Feb; 20(4):1461-7. PubMed ID: 22264764
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of platinum(IV) and platinum(II) complexes containing 1R,2R-cyclohexanediamine as a ligand.
Yamashita T; Hirose J; Noji M; Saito R; Tomida H; Kidani Y
Biol Pharm Bull; 1993 Oct; 16(10):1014-8. PubMed ID: 8287030
[TBL] [Abstract][Full Text] [Related]
12. New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules.
Savić A; Marzo T; Scaletti F; Massai L; Bartoli G; Hoogenboom R; Messori L; Van Deun R; Van Hecke K
Biometals; 2019 Feb; 32(1):33-47. PubMed ID: 30367340
[TBL] [Abstract][Full Text] [Related]
13. Toward overcoming cisplatin resistance via sterically hindered platinum(II) complexes.
Yu H; Gou S; Wang Z; Chen F; Fang L
Eur J Med Chem; 2016 May; 114():141-52. PubMed ID: 26974381
[TBL] [Abstract][Full Text] [Related]
14. Platinum(II) Complexes with 1,10-Phenanthroline and Hydrophilic Alkoxyacetate Ligands as Potential Antitumor Agents.
Sun Y; Wei H; Zhang Q; Zhao X
Chem Biodivers; 2019 Jan; 16(1):e1800373. PubMed ID: 30414350
[TBL] [Abstract][Full Text] [Related]
15. trans-Dichloridopalladium(II) and platinum(II) complexes with 2-(hydroxymethyl)pyridine and 2-(2-hydroxyethyl)pyridine: synthesis, structural characterization, DNA binding and in vitro cytotoxicity studies.
Icsel C; Yilmaz VT; Ari F; Ulukaya E; Harrison WT
Eur J Med Chem; 2013 Feb; 60():386-94. PubMed ID: 23314052
[TBL] [Abstract][Full Text] [Related]
16. {(1R,2R,4R)-4-methyl-1,2-cyclohexanediamine}oxalatoplatinum(II): a novel enantiomerically pure oxaliplatin derivative showing improved anticancer activity in vivo.
Abramkin SA; Jungwirth U; Valiahdi SM; Dworak C; Habala L; Meelich K; Berger W; Jakupec MA; Hartinger CG; Nazarov AA; Galanski MS; Keppler BK
J Med Chem; 2010 Oct; 53(20):7356-64. PubMed ID: 20886814
[TBL] [Abstract][Full Text] [Related]
17. Novel oxaliplatin derivatives with 1-(substituted benzyl)azetidine-3,3-dicarboxylate anions. Synthesis, cytotoxicity, and interaction with DNA.
Sun Y; Cao Z; Gou S; Hu T
Chem Biodivers; 2014 Jan; 11(1):115-25. PubMed ID: 24443431
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxic activities of estrone and estradiol cis-dichloroplatinum(II) complexes.
Kvasnica M; Rarova L; Oklestkova J; Budesinsky M; Kohout L
Bioorg Med Chem; 2012 Dec; 20(24):6969-78. PubMed ID: 23142322
[TBL] [Abstract][Full Text] [Related]
19. Morpholine or methylpiperazine and salicylaldimine based heteroleptic square planner platinum (II) complexes: In vitro anticancer study and growth retardation effect on E. coli.
Rahman FU; Ali A; Khan IU; Duong HQ; Yu SB; Lin YJ; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2017 May; 131():263-274. PubMed ID: 28334655
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization and biological evaluation of platinum(II) complexes with a chiral N-monosubstituted 1,2-cyclohexyldiamine derivative.
Gao C; Gou S; Xu G
Chem Pharm Bull (Tokyo); 2011; 59(7):851-4. PubMed ID: 21720035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
